Evaluate the Use of Glibenclamide on Acute aSAH

Clinical trial NCT05137678 · UNKNOWN

Trial details

NCT number: NCT05137678
Sponsor: Beijing Tiantan Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Subarachnoid Hemorrhage

Start date: 2021-10-19
Primary completion: 2022-10-19
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.